Shanghai,June 8th, 2022 – GenomiCare Biotechnology (Shanghai) Co., Ltd. (hereinafter referred to as GenomiCare Biotechnology) announces acceptance by the Roche Accelerator. With the support from Roche Accelerator, GenomiCare Biotechnology will further devote...
GenomiCare’s sponsored ISPOR Webinar featured a cast of experts from Novartis, Roche, and AstraZeneca in a engaging discussion about Real World Evidence in China. Key takeaways included: On the data, itself: Representativeness and Quality of data is paramount Overall...
On June 29th, Genomicare Biotechnology hosted an ISPOR webinar about the opportunities/challenges with RWE/RWD from China. featuring Sreeram Ramagopalan, PhD, Global Head Real-World Evidence from Roche, Sara Bruce Wirta, PhD, Director RWE & Data Science,...
The 2020 China Technology Fast 50 & China Rising Star lists were officially published by the Beijing office of Deloitte on December 9 and reported by dozens of news outlets. GenomiCare is on list of the 2020 China Rising Star thanks to its “two-wheel-drive”...
GenomiCare is proud to announce that it has won the 2020 Leading Sci-Tech Innovation Company Award for its innovations in the R&D of cancer precision medicine and that Dr. Xu Qiang, the company’s founder and CEO, has been named a 2020 Sci-Tech Innovation Leader....
GenomiCare, Inc. has recently reached a cooperation agreement with AWS on HIPAA compliance. This enables GenomiCare to store, process and utilize masked clinical data in a safer environment and therefore ensures the security and availability of personal health...
